JP MORGAN/CALL/ABBOTT LABORATORIES/100/0.1/17.01.25 Share Price

Warrant

DE000JL03GD8

Market Closed - Bid/Ask 08:15:32 20/06/2024 BST Pre-market 07:31:27
0.96 EUR +7.87% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/100/0.1/17.01.25 1.15 +19.79%
Current month+15.66%
1 month-2.04%
Date Price Change
20/06/24 0.96 +7.87%
19/06/24 0.89 -1.11%
18/06/24 0.9 -4.26%
17/06/24 0.94 +2.17%
14/06/24 0.92 -6.12%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 08:15 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JL03GD
ISINDE000JL03GD8
Date issued 05/04/2023
Strike 100 $
Maturity 17/01/2025 (211 Days)
Parity 10 : 1
Emission price 1.51
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.42
Lowest since issue 0.75
Spread 0.02
Spread %1.72%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
106.6 USD
Average target price
125.4 USD
Spread / Average Target
+17.64%
Consensus